ストックスクリーナーアプリを入手
5.0201
5.26%
-0.2999
前日終値:
$5.32
開ける：
$6.21
24時間の取引高:
11.43M
Relative Volume:
45.43
時価総額：
$2.69M
収益：
-
当期純損益:
$-8.26M
株価収益率:
-0.0936
EPS:
-53.609
ネットキャッシュフロー:
$-12.17M
1週間 パフォーマンス:
-19.28%
1か月 パフォーマンス:
-34.78%
6か月 パフォーマンス:
-91.59%
1年 パフォーマンス:
-98.32%
1日の値動き範囲:
$4.75
$6.70
1週間の範囲:
$4.75
$6.70
52週間の値動き範囲:
$4.75
$333.20
Gri Bio Inc Stock (GRI) Company Profile
GRI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
5.02 | 2.85M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.37 | 120.31B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.31 | 81.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
846.07 | 53.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
351.28 | 46.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.79 | 37.20B | 4.98B | 69.59M | 525.67M | 0.5197 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-09 | 開始されました | H.C. Wainwright | Buy |
Gri Bio Inc (GRI) 最新ニュース
GRI Bio reports positive gene expression data for IPF drug candidate - Investing.com
GRI Bio reports promising Phase 2a data in IPF - TipRanks
GRI Bio stock soars after gene data shows IPF drug targets disease drivers - Investing.com UK
GRI Bio, Inc. Announces Positive Phase 2a Clinical Trial Data for GRI-0621 - TradingView
Early lung fibrosis trial hints drug may help repair damaged lung tissue - Stock Titan
GRI Bio secures U.S. composition of matter patent - TipRanks
New GRI Bio patent covers compounds for inflammatory and autoimmune diseases - Stock Titan
Trade Recap: Is DB Gold Double Short ETN stock a buy or sellTrade Signal Summary & Real-Time Market Sentiment Reports - baoquankhu1.vn
Analysis Recap: Can Viavi Solutions Inc withstand a market correction2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - baoquankhu1.vn
Trade Report: Is GRI Bio Inc in a long term uptrendNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
GRI Bio To Carry Out 1-for-28 Reverse Stock Split On January 26th, 2026 - 富途牛牛
GRI Bio announces 1-for-28 reverse stock split to regain Nasdaq compliance - Investing.com Nigeria
GRI Bio Announces Reverse Stock Split To Regain Minimum Bid Price Nasdaq Compliance - Nasdaq
Gri Bio Announces Reverse Stock Split - TradingView
GRI Bio Announces 1-for-28 Reverse Stock Split - TipRanks
GRI Bio stock falls after announcing 1-for-28 reverse split By Investing.com - Investing.com South Africa
GRI Bio stock falls after announcing 1-for-28 reverse split - Investing.com Nigeria
GRI Bio (NASDAQ: GRI) plans 1-for-28 reverse stock split in January - Stock Titan
GRI Bio slashes share count with 1-for-28 split to meet Nasdaq price rule - Stock Titan
GRI Bio Announces Reverse Stock Split - 富途牛牛
GRI Bio conditionally regains Nasdaq compliance with equity listing rule By Investing.com - Investing.com Nigeria
GRI Bio conditionally regains Nasdaq compliance with equity listing rule - Investing.com
GRI Bio Regains Conditional Compliance With Nasdaq Listing Requirements - TipRanks
Short Covering: Is GCTSWS stock a good pick for beginnersJuly 2025 Chart Watch & Expert Approved Trade Ideas - baoquankhu1.vn
GRI Bio shareholders approve reverse stock split and report Nasdaq compliance - Investing.com Nigeria
GRI Bio Shareholders Authorize Reverse Stock Split Plan - TipRanks
GRI Bio (NASDAQ: GRI) wins reverse split approval and addresses Nasdaq equity risk - Stock Titan
GRI: Reverse stock split and adjournment proposals approved; results to be filed on Form 8-K - TradingView
Gains Recap: Why GRI Bio Inc stock remains on watchlistsJuly 2025 Big Picture & Low Risk Investment Opportunities - Bộ Nội Vụ
Options Flow: What insider trading reveals about GRI Bio Inc. stockEarnings Trend Report & Smart Money Movement Alerts - Bộ Nội Vụ
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Market Recap: What makes GRI Bio Inc stock attractive todayJuly 2025 Snapshot & Fast Moving Trade Plans - baoquankhu1.vn
GRI Bio approves reverse stock split, stockholders vote in favor - MSN
GRI Bio, Inc.Common Stock (NQ: GRI - FinancialContent
GRI Bio announces pricing of $8M public offering - MSN
GRI Bio increases at-the-market offering capacity to $7.38 million - Investing.com Nigeria
GRI Bio reports positive Phase 2a data for IPF treatment By Investing.com - Investing.com Nigeria
GRI Bio Expands At-The-Market Equity Offering Capacity - TipRanks
GRI Bio, Inc. Increases Share Issuance Limit - TradingView — Track All Markets
Can GRI Bio Inc. stock sustain institutional interestCushioning Options Review & trail grip notes for mixed terrain - ulpravda.ru
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Is GRI Bio Inc. stock affected by interest rate hikesWall Street Watch & Safe Entry Trade Signal Reports - Улправда
Can GRI Bio Inc. stock weather global recession2025 Price Targets & Community Consensus Trade Signals - ulpravda.ru
GRI Bio stock rises on positive Phase 2a immune data for IPF treatment - Investing.com Australia
GRI Bio reports positive Phase 2a data for IPF treatment - Investing.com
GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621 - The Manila Times
GRI Bio, Inc. Announces Positive Phase 2a Trial Data for GRI-0621 - TradingView — Track All Markets
GRI Bio Announces Additional Positive Data from Phase 2a - GlobeNewswire
GRI Bio reports six-week interim safety outcomes from trial of GRI-0621 for IPF - MSN
What Wall Street predicts for GRI Bio Inc. stock priceBullish Engulfing Patterns & Small Entry Portfolio - Улправда
What technical signals suggest for GRI Bio Inc. stock2026 world cup usa national team third place match goalkeepers high defensive line group prediction insights - ulpravda.ru
Gri Bio Inc (GRI) 財務データ
収益
当期純利益
現金流量
EPS
0.77%
2.82%
大文字化:
|
ボリューム (24 時間):